BMS Scholar Helps Lead Cancer Research Team Harnessing Protein Power to Stop Tumor Growth

Marxa stands with her arm draping the back of a chair in her lab
Dr. Marxa Figuieredo pictured in her lab. (Purdue University, Rebecca McElhoe)

Dr. Marxa Figueiredo, associate professor of basic medical sciences in the College of Veterinary Medicine, played a leadership role on a team of Purdue University scientists who have created a new therapy option that may help halt tumor growth in certain cancers such as prostate, which is among the most common types of cancer in men.  In 2018, approximately 324,000 men died from cancer in the United States. The combination of lung cancer, prostate cancer, and colorectal cancer equated to half of those deaths.

Large percentages of each of those cancers can be prevented or treated if caught early. “We have designed a therapy that can help recruit immune cells to kill cancer and also help repair bone and tissues damaged by tumors,” said Dr. Figueiredo, who is working with the Purdue Research Foundation Office of Technology Commercialization to patent the innovation. “One of the best features of this technology is that it shows great promise in enabling treatment for many other cancers and diseases that could benefit from halting tumor growth and promoting bone repair.”

The therapy technology is presented in the journal Molecular Therapy: Methods & Clinical Development.  The Purdue team used a protein called interleukin-27, or IL-27, which has shown promise in reducing tumor growth and helping stop cancer from spreading in the body. IL-27 is a cytokine, a kind of protein secreted by cells of the immune system that act as chemical messengers and can help the immune system target cancer and other diseases.

An illustration of protein working to stop tumor growth
Cancer scientists at Purdue aim to use protein power to stop tumor growth and repair damaged bone and tissue.

“Immune cells are naturally attracted to areas of the body with lots of signals that come from proteins such as IL-27,” Dr. Figueiredo said. “So, with our novel approach of targeting the IL-27 to the tumor or bone cells, we can use these proteins to produce signals that bring healthy cells to areas of the body with cancer or other disease and kill the tumors and begin the process of repairing bone and other musculoskeletal tissues.”

Dr. Figueiredo said the new Purdue therapy technology has applications for people and animals with many different types of cancer, including breast and lung, and other diseases where protein targeting could improve the immune system’s response.

The research team and the Purdue Research Foundation Office of Technology Commercialization are looking for partners for this cancer therapy technology. For more information on licensing and other opportunities, contact Joseph Kasper of OTC at jrkasper@prf.org.  Click here to view a complete news release about the research.

Writer(s): Chris Adam, Purdue News Service | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

This week, we extend our heartfelt gratitude to Dr. Jim Weisman, assistant dean for clinical education and clinical associate professor, for his many years of dedicated service to the Purdue Veterinary Medicine community.

One Health Film Festival Features Purdue Veterinary Medicine One Health Research

The Purdue University College of Veterinary Medicine has a longstanding commitment to One Health research and education. So it was natural for the college to agree to participate in a film festival orchestrated by an organization it is a member of called the Clinical and Translational Science Award One Health Alliance, or COHA.

PVM Puts Best Paw Forward at 2025 Open House Tomorrow

Lynn Hall will undergo a metamorphosis by nightfall tonight (Friday, April 11) as the Purdue University College of Veterinary Medicine prepares for the annual Open House tomorrow, Saturday, April 12. Planned by PVM students, the annual event will attract people of all ages who want to see animals and learn about animal health and the profession of Veterinary Medicine.

Upcoming Purdue Day of Giving Enables People and Pups to Unite for a Good Cause

Purdue University’s ever-popular 24-hour online-based annual fundraising effort – the Purdue Day of Giving – will take place Wednesday, April 30. That’s when Boilermakers across the world will have the opportunity to rally around this year’s theme of “All Hail!” – words taken from Purdue’s beloved fight song. For the College of Veterinary Medicine, this special day of giving will focus attention on ways Boilermaker alumni, fans and friends can support animal and human health and well-being by contributing to a variety of Purdue Veterinary Medicine funds.

Lucy’s Story

When an eight-year-old shepherd-mix dog named Lucy was injured after tragically getting struck by a car, co-parents Matt and Gretchen Walker were told that she would likely never walk again. That was over three years ago, in May of 2021. The Walkers, of Brookston, Indiana, had raised Lucy since she was a puppy, and knew that her life was nothing short of worth fighting for. “If she was willing to live, I was willing to do whatever it took,” Matt said as he recounted the story recently.